Clinical Trial Update: Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy [NA]

View source ↗

Summary

A clinical trial update evaluating tafluprost as an adjunct to medical therapy for residual glaucoma after trabeculectomy; the status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Zioptan (tafluprost)

Snippet

Sponsor: wangdabo | Conditions: Glaucoma; Drugs | NA | Status: UNKNOWN